Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease

Diabetes/metabolism Research and Reviews
I BarchettaM G Cavallo

Abstract

Procollagen-III peptide (PIIINP) is a marker of fibrosis associated with increased cardiometabolic risk and progression of chronic liver diseases such as nonalcoholic fatty liver disease (NAFLD) and steatohepatitis; its association with type 2 diabetes mellitus (T2DM) has not been elucidated yet. The aim of this study was to investigate the relationship among circulating PIIINP levels, metabolic traits, and body fat distribution in subjects with T2DM with or without NAFLD. Data from 62 T2DM subjects recruited in our diabetes outpatient clinics at Sapienza University of Rome, Italy, were analysed. Participants underwent metabolic and inflammatory profiling (CRP, TNFα, IL-6, IL-8, WISP1, and adiponectin) and magnetic resonance imaging for diagnosing NAFLD on the basis of hepatic fat fraction (≥5.5%) and quantifying visceral and subcutaneous adipose tissue (AT) areas. Serum PIIINP was measured by human-PIIINP ELISA kits. Higher PIIINP levels correlated with greater BMI and visceral AT area and were associated with systemic signatures of AT-associated inflammation-ie, higher WISP-1, IL-8, and lower adiponectin levels; conversely, PIIINP did not differ significantly between T2DM patients with or without NAFLD and were not associated...Continue Reading

References

Apr 1, 1994·Diabetes Research and Clinical Practice·I N MigdalisM Samartzis
Aug 24, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·D QuilliotF Zannad
May 27, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Richard K SterlingUNKNOWN APRICOT Clinical Investigators
Apr 22, 2008·Alcoholism, Clinical and Experimental Research·Charles S LieberUNKNOWN Veterans Affairs Cooperative Study 391 Group
Nov 6, 2008·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Jose R RomeroSudha Seshadri
Jun 16, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Amy G ShahUNKNOWN Nash Clinical Research Network
Jun 10, 2010·Obesity Surgery·Zobair M YounossiAncha Baranova
Oct 1, 2010·The New England Journal of Medicine·Giovanni TargherEnzo Bonora
Oct 5, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Naim AlkhouriValerio Nobili
May 6, 2011·International Journal of Cancer. Journal International Du Cancer·Chenggang WangLiangwen Wang
Aug 30, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sudeep TanwarWilliam M Rosenberg
Apr 10, 2014·Journal of Clinical Gastroenterology·Flavia F FernandesRenata M Perez
Apr 29, 2014·American Journal of Epidemiology·Isha AgarwalKenneth J Mukamal
Jun 25, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Katharine M IrvineElizabeth E Powell
Aug 19, 2015·Metabolism: Clinical and Experimental·Isha AgarwalKen J Mukamal
Sep 12, 2015·Journal of Clinical and Translational Hepatology·Evan J RaffAshwani K Singal
May 18, 2016·The Lancet. Diabetes & Endocrinology·Norbert StefanHans-Ulrich Häring
Jul 22, 2016·Journal of Pediatric Endocrinology & Metabolism : JPEM·Rasha Tarif HamzaAmira Ibrahim Hamed
Oct 22, 2016·American Journal of Physiology. Gastrointestinal and Liver Physiology·Morten A KarsdalDetlef Schuppan
Mar 21, 2017·Current Pharmaceutical Design·Joana Moura FerreiraInês Falcão-Pires
Aug 3, 2017·Cell Metabolism·Norbert StefanHans-Ulrich Häring

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.